The team built a diploid yeast strain in which both copies of the SOD1 gene had been deleted, creating a hybrid background containing roughly 50,000 sequence differences between its two parental genomes. This design allowed the researchers to map, with extraordinary resolution, every loss of heterozygosity event that accumulated as cells divided. After subculturing 32 independent isolates for hundreds of generations, whole-genome sequencing revealed a staggering catalogue of damage. Single nucleotide variations accumulated at 13 times the wild-type rate, loss of heterozygosity rose 12-fold, large chromosomal rearrangements increased 4-fold, and aneuploidy—the gain or loss of entire chromosomes—surged an astonishing 48-fold above normal levels.

The scale and diversity of these lesions underscored that Sod1 deficiency does not merely nudge the genome toward instability; it fundamentally rewrites the rules of genome maintenance. The researchers detected 322 interstitial and 134 terminal loss-of-heterozygosity events across their isolates, occurring at rates 15- and 16-fold higher than in wild-type cells, respectively. Gene conversion tracts—the stretches of DNA copied from one homologous chromosome to repair damage on the other—were also markedly longer in the mutant, averaging 10.8 kilobases compared with 5.9 kilobases in healthy cells. Most structural rearrangements were flanked by Ty retrotransposon sequences, pointing to unequal recombination between repetitive elements as a major driver of large-scale chromosome changes.

Perhaps the most striking result came when the researchers repeated the experiment under anaerobic conditions. Deprived of oxygen, the sod1 mutant’s genomic chaos vanished almost entirely: mutation rates fell to wild-type levels and recombination rates dropped dramatically. Supplementing the growth medium with glutathione, a potent cellular antioxidant, similarly cut mutation and recombination frequencies by more than half. Together, these experiments identified reactive oxygen species as the sole executioner behind the genomic storm, confirming that the instability arises from direct chemical attack on DNA rather than from indirect disruption of repair machinery or metabolic collapse.

The mutational fingerprint left by Sod1 loss proved highly distinctive. All six classes of base substitutions increased, but transversions dominated, particularly C:G to A:T changes concentrated within 5′-CCA-3′ sequence motifs. This pattern is the classic signature of 8-oxoguanine, an oxidized form of guanine that mispairs with adenine during replication, producing the characteristic transversion after a second round of DNA copying. The finding directly implicates 8-oxoguanine overproduction as the molecular engine of Sod1-deficient mutagenesis, and it links the enzyme’s antioxidant function to a specific, measurable chemical lesion on DNA.

Dissecting how cells cope with these lesions revealed a sophisticated hierarchy of repair and bypass. The base excision repair glycosylase Ogg1 emerged as the frontline defense: deleting OGG1 alone caused a 19-fold rise in C:G to A:T transversions, and combining OGG1 deletion with SOD1 deletion produced a synergistic 7.5-fold increase over the ogg1 mutant alone. By these calculations, Ogg1-mediated excision corrects roughly 90 percent of the 8-oxoguanine lesions generated in the absence of Sod1. When repair is overwhelmed, translesion synthesis polymerases take over, and here the outcomes diverge sharply. DNA polymerase eta, encoded by RAD30, performs relatively accurate bypass by inserting cytosine opposite the oxidized base, preventing about a third of the characteristic transversions. In contrast, the error-prone polymerase zeta and its partner Rev1 account for approximately two-thirds of all Sod1-induced point mutations, illustrating the costly trade-off between completing replication and preserving sequence fidelity.

Timing analysis of recombination events added another layer of mechanistic insight. Using a colony-sectoring assay on chromosome IV, the team showed that about 65 percent of mitotic crossovers in sod1 mutants were initiated by double-strand breaks arising during the G1 phase of the cell cycle, closely mirroring the pattern in wild-type cells. Fluorescence microscopy of Rad52 repair foci confirmed a four-fold increase in spontaneous DNA breaks. Intriguingly, the distribution of crossover breakpoints was not random: 33 of 35 events on chromosome IV clustered distal to the SSD1 locus, a bias the researchers traced to post-mutational selection rather than intrinsic recombination hotspots. Restoring a functional SSD1 allele, which improved fitness in the sod1 background, redistributed breakpoints uniformly, demonstrating that observed genomic landscapes reflect both where damage occurs and which recombinant cells survive to form colonies.

The study then turned to human disease, testing eight ALS-associated SOD1 variants in the yeast system. Wild-type human SOD1 fully rescued the growth defects and genomic instability of yeast lacking endogenous Sod1, confirming deep functional conservation. But the clinical variants were not created equal. The H48Q mutation, which disrupts a copper-binding residue essential for catalytic activity, shattered genome stability, producing 8- and 10-fold increases in mutation and recombination rates alongside severe growth impairment. The G85R and S133N variants showed moderate effects, while the well-known A4V, G36R, D90A, and G93A variants remained essentially benign in this context. These results suggest that for a subset of ALS patients, loss of genomic protection—driven by failure to quench nuclear reactive oxygen species—may constitute an additional, mutation-specific pathogenic mechanism beyond the prevailing toxic gain-of-function model of protein aggregation.

Notably, the researchers found that human Sod1 is far more tolerant of amino acid substitutions than its yeast counterpart, a difference they attribute to the extraordinary structural robustness of the human enzyme, which remains stable even in metal-deficient states. This resilience likely reflects evolutionary pressure in long-lived organisms to protect the proteome against decades of somatic mutation. The work also carries a cautionary message for cancer therapy: because tumor cells often depend on elevated Sod1 to manage their oxidative burden, pharmacological inhibition of the enzyme, while potentially cytotoxic, risks triggering a mutational burst that could accelerate the emergence of drug-resistant clones. By mapping the full genomic consequences of antioxidant failure—from single nucleotides to whole chromosomes—this study establishes a mechanistic framework for understanding how metabolic defense and genome integrity are inseparably coupled in eukaryotic life.

Subject of Research: The role of superoxide dismutase 1 in protecting eukaryotic genome stability against oxidative DNA damage

Article Title: Decoupling metabolic defense: Mutational and recombinational chaos in Sod1-deficient cells

Article References: Sui, Y., Zheng, D.-Q., Wang, Y., Zhao, S.-S., Li, K.-J., Ye, C., & Zhang, K. (2026). Decoupling metabolic defense: Mutational and recombinational chaos in Sod1-deficient cells. PLOS Genetics, 22(10), e1012326. https://doi.org/10.1371/journal.pgen.1012326

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012326

Keywords: Sod1, genome instability, reactive oxygen species, 8-oxoguanine, yeast, loss of heterozygosity, aneuploidy, base excision repair, translesion synthesis, ALS, SOD1 mutations, oxidative stress